Key facts
- It has raised $84.9M; the latest was Early Stage VC ($43.1M) in Feb 2026.
- Notable investors include HSG (Hong Kong), CAS Star, IDG Capital, Shunwei Capital, Legend Capital — 15 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 15 names
- ·Watchlist + deal alerts for BCIFlex
- ·The full record, as it builds
Funding rounds
No funding rounds for BCIFlex are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About BCIFlex
Developer of neural interface technology intended for direct communication between biological neural activity and external systems. The company offers implantable and external interaction methods, flexible electrode architectures, signal acquisition and modulation capabilities, integrated hardware and software components for clinical and research environments, enabling healthcare practitioners and scientific investigators to achieve consistent performance and controlled operational safety.
- Sector
- Healthcare
- HQ
- Beijing, China
- Founded
- 2022
- Website
- bciflex.com/
- Ownership
- Privately Held (backing)
BCIFlex doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in BCIFlex shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on BCIFlex in its N-PORT filings yet. We sweep new filings monthly.